Susannah Wade

Background

About Susannah Wade

Purpose driven, impact focused healthcare communicator and advocacy leader. Trusted partner to Oncology, HIV and Hepatitis Patient Advocacy Groups with demonstrated advocacy results in Oncology, HIV and Hepatitis. Led Gilead Australia & New Zealand patient advocacy engagement since 2020, resulting in Gilead’s #1 ranking amongst Pharma for corporate reputation. Twice nominated for Health Industry Hub Corporate Communication Professional of the year (2023 & 2024). Demonstrated success in co-creating with patients, academia and clinicians multiple award winning, multi-year patient and community engagement programs including Gilead and NAPWHA HIV Community Champions, Young Emerging Scientists in HIV, ourTNBC Hub and CAR-T patient council. Champion for Indigenous Health. Co-created and secured US$3M Gilead funding for Indigenous health program funding for GLOWS Grant, in partnership with Lowitja Institute and Poche Centre for Indigenous Health. Project lead for Gilead Reflect and Innovate RAPs. Skilled in corporate affairs, media relations, environment shaping, product launches, patient advocacy and stakeholder engagement and public awareness campaigns with 20 years experience, working in pharmaceutical, private and public health care sectors.